抑郁症混合状态是什么?-双极性之外的相关因素
Minoru Takeshima1,2,3, Takeshi Inoue3
1Department of Psychiatry, Shibata Hospital, Takaoka City, Japan.
Bipolar disorders
|February 24, 2025
概括
贝纳齐的抑郁混合状态 (DMX) 与双相情感障碍和焦虑困扰有关,表明预后不佳. 对于DMX来说,更严格的DSM-5标准显示其患病率很低,这限制了其在诊断双极性情绪时的临床实用性.
科学领域:
- 精神病学是一个精神病学.
- 情绪障碍 情绪障碍 情绪障碍
- 诊断标准 诊断标准 诊断标准
背景情况:
- 抑郁混合状态 (DMX) 存在诊断上的挑战.
- 区分不同的DMX定义对于准确的诊断和治疗至关重要.
研究的目的:
- 将贝纳齐抑郁混合状态 (DMX) 的相关因素与DSM-5混合特征标准 (DSM-5-DMX) 进行比较.
- 调查这些DMX定义与双相情感,焦虑焦虑和其他并发症的关系.
主要方法:
- 对160名患有重大抑郁症发作 (MDE) 的患者进行了回顾性分析.
- 研究了DMX定义与双相情感障碍 (BD),焦虑性焦虑 (ANXD),自闭症谱系障碍,多动症和年龄的关联.
- 统计分析包括赔率比率和置信区间.
主要成果:
- 在48.8%的患者中发现了贝纳齐的DMX;在1.9%的患者中发现了DSM-5-DMX.
- 贝纳齐的DMX与BD (OR 3.70) 和ANXD (OR 6.14) 强烈相关.
- 贝纳齐的DMX与不良预后和不良抗抑郁药物影响有关. 一个修改的DSM-5标准 (≥2症状) 也与BD和ANXD相关.
结论:
- 贝纳齐的DMX是一个临床相关的双极性和焦虑性焦虑的指标,与预后不佳有关.
- DSM-5-DMX标准过于严格,在临床实践中识别双极性疾病的敏感性较低.
- 需要进一步的研究来验证这些发现,并完善DMX诊断标准.
相关概念视频
Bipolar Disorder
43
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
43
Depressive Disorders: Etiology
29
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
29
Depression: Overview
208
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
208
Depressive Disorders: MDD and Dysthymia
30
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
30
Mania and Antimanic Drugs: Overview
113
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
113
Antidepressant Drugs: MAOIs and Other Agents
178
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
178


